James Paul Scopa
CIK 1356950 · last filed 2025-12-10
James Paul Scopa is a corporate insider who has filed 46 SEC Form 4 insider transactions across 6 companies since 2009. The most recent filing, for ADVM, was dated Dec 10, 2025. Across all open-market trades the lifetime net is +$1.9M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $966.7K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$966.7K
6
46
$1.93M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. (ADVM) Delisted | Director | 3,334 | $4.36 | $14.5K | $297.7K | 15 | 2025-12-10 |
| ALGS | Director | 183,083 | $5.28 | $966.7K | $0 | 7 | 2025-06-26 |
| DICE Therapeutics, Inc. (DICE) Delisted | Director | 0 | $47.55 | $0 | -$188.5K | 8 | 2023-08-09 |
| Histogen Inc. (CNAT) Delisted | Director | 1,010,099 | — | — | $1.82M | 5 | 2018-06-25 |
| TriVascular Technologies, Inc. (TRIV) Delisted | Director | 0 | — | — | $0 | 2 | 2016-02-04 |
| MEMY | 10%+ Owner | 0 | $22.23 | $0 | $0 | 1 | 2009-01-05 |
Recent Filings
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-10 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Mixed | −10,333 | $0 | EDGAR |
| 2025-06-26 | ALGS | Grant (A) | — | $0 | EDGAR |
| 2025-06-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-28 | ALGS | Grant (A) | — | $0 | EDGAR |
| 2024-06-20 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-28 | ALGS | Mixed | — | $0 | EDGAR |
| 2024-02-09 | Adverum Biotechnologies, Inc. (ADVM) Delisted | Buy (P) | +100,000 | $135.0K | EDGAR |
| 2023-10-27 | ALGS | Grant (A) | +183,083 | $138.6K | EDGAR |
| 2023-08-09 | DICE Therapeutics, Inc. (DICE) Delisted | Disp (D) | −40,921 | $0 | EDGAR |
| 2023-08-03 | DICE Therapeutics, Inc. (DICE) Delisted | Gift (G) | −2,420 | $0 | EDGAR |